Seroba Lifesciences is a European life sciences venture capital firm focused on value creation through backing innovations in biotech and medtech.

Seroba Lifesciences

Access Industries is a privately-held industrial group with long-term holdings worldwide. The company's investments span multiple sectors, focusing on established and emerging industries where it can add value and enhance business performance.

Access Industries

Bpifrance, also known as the Banque publique d'investissement, is a French public sector investment bank formed as a joint venture of two state-owned enterprises: the Caisse des dépôts et consignations and EPIC BPI-Groupe. It has been designated as a Significant Institution and is directly supervised by the European Central Bank.

Bpifrance

Complement Therapeutics is a spin-out from The University of Manchester that focuses on developing treatments for Complement-related diseases, particularly age-related macular degeneration. The company conducts translational research to gain insights into the Complement System and its dysregulation in macular degeneration.

Metric
Company Name	Seroba Lifesciences	Access Industries	Bpifrance	Complement Therapeutics
Symbol
MSH ID	COM:SEROBA-LIFESCIENCES	COM:ACCESSINDUSTRIES	COM:BPIFRANCE	COM:COMPLEMENTTX
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Commercial & Professional Services	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Diversified Holdings	Financial Services & Finance	Biotechnology
Country	IE	US		GB
Stage
Employee Count		111	1.00K
Website	seroba-lifesciences.com	accessindustries.com	bpifrance.com	complementtx.com
LinkedIn		access-industries		complement-therapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	606	3.62K
Web Traffic Growth	-0.87	-0.21
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score		49.07
28-Day Growth Score		58.38
90-Day Growth Score		15
365-Day Growth Score		45.64

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SEROBA-LIFESCIENCES

Seroba Lifesciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue